Abstract

Objective : Urinary tract infection is one of the commonest infections in the pediatric age group. The emergence of resistance to various antibiotics has posed many difficulties in treating such patients. This study has been done to compare the efficacy of fosfomycin & ciprofloxacin in pediatric Urinary tract infection (UTI). Study Design: Randomized Control study Place and Duration: Akhtar Saeed Medical College/ Farooq Hospital. July, 2021 to Dec, 2021 Methodology: This randomized controlled clinical trial is done at the Department of Pediatrics, Akhtar Saeed Medical College/ Farooq Hospital. One hundred and thirty individuals who met the criteria for UTI were recruited. The patients were split into two groups at random. Patients in Group A received 15–20mg/kg of oral Ciprofloxacin twice daily (BD) for 7 days, whereas those in Group B received 150–300mg/kg of oral fosfomycin all at once. Results: One-hundred and ten patients included in this trial. In group A mean age of the paties was 6.4±2.8 years and in group B patients had mean age 7.7±3.0 years. There were 35 males (63.6%) and 20 females (36.4%) in group A and in group B 33 males (60%) and 22 females (40%). As per effectiveness we found that fosfomycin was effective in 42 patients (76.4%) and ciprofloxacin was efficacious in 30 patients (54.5%) with p-value 0.016. Conclusion: When comparing the treatment of children with acute uncomplicated urinary tract infections, the results showed that a single oral dosage of fosfomycin was substantially more effective than ciprofloxacin. Keywords: Antibiotics, Resistance, uropathogens, paediatrics, UTI, gram-negative,

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.